Leadership

Andrew is a proven leader with over thirty years of experience building and managing teams at the intersection of the physical and computational sciences with medicine and biology, most recently serving as InterVenn's General Manager and Executive Vice President of Operations. He possesses in-depth and working knowledge in strategic planning, clinical research and trials, operations, project management, technology transfer and business/partnership development. Prior to InterVenn, Andrew was the Chief Science Officer at Standard BioTools, Inc (formerly Fluidigm), and was the liaison and bridge to the research community, identifying opportunities to address unmet needs in human health. He also served as the Genomics Business Unit Leader and was responsible for Product Marketing and Product Management.

Andrew also was the Director of Strategic Scientific Initiatives and Partnerships at the Frederick National Laboratory for Cancer Research and held faculty positions in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University. Andrew oversaw the operation of the shared services for the Kimmel Cancer Center and his research focused on systems biology approaches and mass spectrometry to understanding mechanisms of resistance to treatment of breast cancer and biomarkers of response. He has published extensively and served on the editorial boards of Cancer Research and The American Journal of Pathology.